Moderating effects of plasma glial fibrillary acidic protein along the Alzheimer's disease continuum

AD biomarkers were measured in two demographically and clinically distinct cohorts. Plasma GFAP moderated Aβ-PET to p-tau associations in both UCSF and 1FLADRC. Cohort-dependent, GFAP moderated p-tau to neurodegeneration and cognition associations. All moderations revealed strengthened disease associations with higher plasma GFAP. Plasma GFAP may help identify individuals at greatest risk of AD-related decline.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-09-01
DOI
https://doi.org/10.1002/alz.70626
Citations
1
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
1.16

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Moderating effects of plasma glial fibrillary acidic protein along the Alzheimer's disease continuum

Lawren VandeVrede, Mark Sanderson‐Cimino, Brandon Chan, Julio C. Rojas et al.
1 citations
Alzheimer s & Dementia
Alzheimer's disease research and treatments
1.16
article

Moderating effects of plasma glial fibrillary acidic protein along the Alzheimer's disease continuum

Lawren VandeVrede, Mark Sanderson‐Cimino, Brandon Chan, Julio C. Rojas, Franchesca Arias, Warren Barker, Breton M. Asken, Adam M. Staffaroni, Renaud La Joie, David E. Vaillancourt, Joel H. Kramer, Rosie E. Curiel, Shannon Y. Lee, Melissa J. Armstrong, Emily F. Matusz, Mónica Rosselli, Michael Marsiske, Wei‐en Wang, Valentina E. Diaz, Gil Dan Rabinovici, Shellie‐Anne Levy, Sruti Rayaprolu, Jesse C. DeSimone, Glenn E. Smith, David Loewenstein, Brenda A. Wiens, Steven T. DeKosky, Idaly Vélez-Uribe, Emily W. Paolillo, Olivia M. Emanuel, Rowan Saloner, Tatjana Rundek, Ranjan Duara, Argentina Lario Lago, Kaitlin B. Casaletto, Julia D Webb
article en
1 citations

Abstract

AD biomarkers were measured in two demographically and clinically distinct cohorts. Plasma GFAP moderated Aβ-PET to p-tau associations in both UCSF and 1FLADRC. Cohort-dependent, GFAP moderated p-tau to neurodegeneration and cognition associations. All moderations revealed strengthened disease associations with higher plasma GFAP. Plasma GFAP may help identify individuals at greatest risk of AD-related decline.

Alzheimer s & DementiaVol. 21(9)
University of Miami (US), University of California, San Francisco (US), University of Florida Health (US), University of Florida (US), Mount Sinai Medical Center (US), Florida Atlantic University (US), Florida College (US)
Alzheimer's Association, Larry L. Hillblom Foundation, National Institutes of Health, National Institute on Aging
Openalex Percentile: Top 18%
Alzheimer's disease research and treatments
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.